This report provides an overview of the Department of Defense’s infectious disease efforts related to global health. The report looks at how DoD’s infectious disease activities are organized internally and coordinated with other U.S. government agencies and partners.
HIV/AIDSSee more about HIV/AIDS
- state & global data
- view as grid
- view as list
This session will explore how policy makers and programme managers can work with the current state of knowledge and unanswered questions about what works in HIV prevention to develop strategic, combination prevention responses.
AIDS 2012: Comprehensive HIV Prevention for People Who Use Drugs: Ways Forward for Inclusion of Needle and Syringe Exchange Programmes
This session will address the potential impacts of restrictions on NSEPs, and propose ways forward for public health actors, community stakeholders, and drug users themselves to maintain and expand comprehensive services, including needle and syringe exchanges, despite the limitations in funding, restrictive political environments, and other barriers to the implementation of this preventive intervention.
This session will bring together some of these global leaders to discuss how, in their experience, public-private partnerships are an innovative way to bring together diverse organizations and target the same goal of efficient local programmes that, at the same time, translate into powerful advocacy tools at the global level.
This session will present examples of in-country ownership for developing strategies and solutions for achieving national HIV goals, drawing on the perspectives of government and business sectors.
Official Press Conference
The Caribbean region is looking beyond the MDGs, to develop a new agenda for sustainable development and HIV, based on four pillars: unified gender and SHR, equity and human rights, participation of Caribbean women, girls and men, and partnerships.
This panel examines the elements of success and the areas for innovation amongst youth leaders and allies from around the world.
This session will focus on the timely and important issue of antiretroviral therapy (ART) as a prevention intervention and will be of interest to clinicians, researchers, programme managers and policy makers. The opportunities and challenges implicit in this approach will be presented by various speakers, each bringing a different perspective on the issue.
The session will examine from a pragmatic perspective how plans can be shaped and efforts mobilized in order to achieve maximum public health impact utilizing the various resources available including PEPFAR, the Global Fund, private sector, and in-country resources.